Literature DB >> 33883209

Shape related features of intracranial aneurysm are associated with rupture status in a large Chinese cohort.

Yuting Wang1, Meixiong Cheng2, Sijie Liu1, Guanglan Xie1, Ling Liu3, Xiao Wu4, Ajay Malhotra5, Mahmud Mossa-Basha6, Chengcheng Zhu6.   

Abstract

BACKGROUND: To investigate the prevalence of small ruptured saccular intracranial aneurysms (sIA) in a Chinese cohort and to identify factors associated with rupture status of sIAs.
METHODS: Consecutive patients with confirmed sIAs by DSA from January 2015 to July 2019 were included. Demographic and aneurysmal features, including maximal diameter, location, irregularity (lobulated or with blebs), and aspect ratio (AR, defined as height divided by neck width) were recorded and analyzed. Mixed effect logistic regression was used in multivariate analysis.
RESULTS: We analyzed 1514 sIAs in a Chinese cohort of 1216 patients, including 651 ruptured and 863 unruptured sIAs. Median aneurysm size was 5.7 mm for ruptured aneurysms, with 66.1% <7 mm in maximal diameter, and 40.2% measuring <5 mm. The median PHASES score of ruptured sIAs was 5. In multivariate analysis, male sex, hypertension, locations other than the internal carotid artery, irregularity (lobulated or with blebs), and higher AR were independently associated with rupture status (OR for irregularity, 2.88, 95% CI 2.20 to 3.77, p<0.001; OR for AR, 1.12, 95% CI 1.01 to 1.24, p=0.036). However, maximal diameter was not significantly associated with rupture status (p=0.72).
CONCLUSIONS: In this cohort, ruptured sIAs were frequently smaller than 7 mm. Shape related features, such as irregularity and higher AR, were associated with the ruptured status of sIAs, irrespective of diameter. PHASES seems to be inadequate in sIA risk stratification. Shape related parameters may be further investigated in prospective studies. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  aneurysm; angiography; brain; hemorrhage; subarachnoid

Mesh:

Year:  2021        PMID: 33883209     DOI: 10.1136/neurintsurg-2021-017452

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  6 in total

Review 1.  Unruptured cerebral aneurysm risk stratification: Background, current research, and future directions in aneurysm assessment.

Authors:  Michael A Silva; Stephanie Chen; Robert M Starke
Journal:  Surg Neurol Int       Date:  2022-04-29

2.  Different Hemodynamic Characteristics and Resulting in Different Risks of Rupture Between Wide-Neck and Narrow-Neck Aneurysms.

Authors:  Heng Wei; Qi Tian; Kun Yao; Jianfeng Wang; Peibang He; Yujia Guo; Wenrui Han; Wenhong Gao; Mingchang Li
Journal:  Front Neurol       Date:  2022-04-25       Impact factor: 4.086

3.  Construction and Evaluation of Multiple Radiomics Models for Identifying the Instability of Intracranial Aneurysms Based on CTA.

Authors:  Ran Li; Pengyu Zhou; Xinyue Chen; Mahmud Mossa-Basha; Chengcheng Zhu; Yuting Wang
Journal:  Front Neurol       Date:  2022-04-11       Impact factor: 4.003

4.  Homocysteine Levels Are Associated With the Rupture of Intracranial Aneurysms.

Authors:  Sen Wei; Xin Yuan; Dongdong Li; Xinbin Guo; Sheng Guan; Yuming Xu
Journal:  Front Neurosci       Date:  2022-07-14       Impact factor: 5.152

5.  A web-based dynamic nomogram for rupture risk of posterior communicating artery aneurysms utilizing clinical, morphological, and hemodynamic characteristics.

Authors:  Heng Wei; Wenrui Han; Qi Tian; Kun Yao; Peibang He; Jianfeng Wang; Yujia Guo; Qianxue Chen; Mingchang Li
Journal:  Front Neurol       Date:  2022-09-14       Impact factor: 4.086

6.  The Analysis of Morphoradiological Parameters in Predicting Risk of Basilar Artery Tip Aneurysm Rupture: A Retrospective Cohort Study.

Authors:  Abdulaziz Al-Sharydah; Abdulrahman Al-Abdulwahhab; Sari Al-Suhibani; Afnan Al-Muhanna; Abdullah Abohimed; Abdulmonem AlSharidah; Faisal Alabbas
Journal:  Int J Gen Med       Date:  2021-07-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.